EAAI Journal 2026 Journal Article
A semi-supervised multimodal fusion framework with adversarial contrastive learning for Alzheimer's disease diagnosis
- Haowen Liu
- Lei Shi
- Yucheng Shi
- Yameng Zhang
- Guohua Zhao
- Yufei Gao
Multimodal neuroimaging data provide complementary structural and functional information for Alzheimer's disease (AD) diagnosis. However, acquiring a large-scale multimodal dataset with precise annotations is resource-intensive and incurs substantial costs. Effectively fusing relevant information across modalities also remains a significant challenge. Existing methods are often constrained by modeling intra-modality specific features and inter-modal shared information in isolation, overlooking their critical interactions. Additionally, the heterogeneity among modalities introduces a major obstacle to achieving reliable cross-modality feature alignment. To tackle these problems, we propose an end-to-end semi-supervised multimodal fusion framework with adversarial contrastive learning. Specifically, a pseudo-labeling strategy is designed to make full use of unlabeled data by regulating the quality of pseudo-labels with a threshold. To adaptively capture inter-modal shared characteristics while preserving the unique properties of intra-modality, we design a Dual-phase Inter–Intra Attention Fusion Unit that effectively exploits the interactions between different modalities. Moreover, to achieve efficient alignment of multimodal data at both the feature and subject levels, we develop a hierarchical alignment strategy based on adversarial contrastive learning. This strategy maps features into a shared latent space and promotes the proximity of inter-modal paired samples within that space, thereby simultaneously mitigating distributional discrepancies and resolving semantic inconsistencies across modalities. Extensive experiments conducted on two independent public datasets demonstrate that the proposed framework performs excellently in AD diagnosis compared with existing approaches, notably achieving an accuracy of 92. 00 (±1. 00)% on ADNI1 with only 40% labels.